Diomed Holdings Inc - Current report filing (8-K)
February 25 2008 - 8:41AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
February
21, 2008
Diomed
Holdings, Inc.
|
Delaware
|
000-32045
|
84-1480636
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
1
Dundee Park
Andover,
MA
|
01810
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(978-475-7771)
Item
7.01
Regulation
FD Disclosure
On
February 21, 2008, the United States Court of Appeals for the Federal Circuit scheduled for April 10, 2008 a hearing on the appeal
taken by AngioDynamics, Inc. and Vascular Solutions, Inc. of the $14.6 million judgment awarded to Diomed Holdings, Inc. as a result of the March 2007 trial of
Diomed’s successful patent infringement lawsuit regarding
Diomed’s
United States Patent Number 6,398,777 for the endovascular laser treatment
of
varicose veins.
The
Court is expected to issue its decision on the appeal at a later date.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
Diomed
Holdings, Inc.
(Registrant)
|
|
|
|
|
Date:
February 25, 2008
|
By:
|
/s/ DAVID
B.
SWANK
|
|
|
Name:
David
B. Swank
Title:
Chief
Financial Officer
|
|
|
|
Diomed (AMEX:DIO)
Historical Stock Chart
From May 2024 to May 2024
Diomed (AMEX:DIO)
Historical Stock Chart
From May 2023 to May 2024
